India Renal Foundation Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 15-05-2024
- Paid Up Capital ₹ 0.39 M
as on 15-05-2024
- Company Age 22 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -14.89%
(FY 2022)
- Profit -757.21%
(FY 2022)
- Ebitda -364.67%
(FY 2022)
- Net Worth -7.64%
(FY 2022)
- Total Assets -6.70%
(FY 2022)
About India Renal Foundation
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 0.39 M, as per Ministry of Corporate Affairs (MCA) records.
Trilokbhai Parikh, Beena Handa, and Parikh Arun serve as directors at the Company.
- CIN/LLPIN
U85110GJ2002NPL040355
- Company No.
040355
- Company Classification
Public Not For Profit Company
- Incorporation Date
15 Jan 2002
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at India Renal Foundation?
Board Members(3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Trilokbhai Parikh | Director | 06-Aug-2018 | Current |
Beena Handa | Director | 15-Jan-2002 | Current |
Parikh Arun | Additional Director | 05-Jan-2024 | Current |
Financial Performance of India Renal Foundation.
India Renal Foundation, for the financial year ended 2022, experienced significant reduction in revenue, with a 14.89% decrease. The company also saw a substantial fall in profitability, with a 757.21% decrease in profit. The company's net worth dipped by a decrease of 7.64%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of India Renal Foundation?
In 2020, India Renal Foundation had a promoter holding of 99.82% and a public holding of 0.18%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Gulmohar Greens-Golf And Country Club LimitedActive 19 years 6 months
Trilokbhai Parikh is a mutual person
- Gulmohar India Education FoundationActive 2 years 3 months
Trilokbhai Parikh and Parikh Arun are mutual person
- Gulmohar Renal FoundationActive 1 year 11 months
Trilokbhai Parikh and Parikh Arun are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at India Renal Foundation?
Unlock and access historical data on people associated with India Renal Foundation, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of India Renal Foundation, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped India Renal Foundation's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.